Chesley Taft & Associates LLC Merck & Co., Inc. Transaction History

Chesley Taft & Associates LLC

  • $2.08 Billion
  • Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 65,847 shares of MRK stock, worth $6.79 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
65,847
Previous 66,037 0.29%
Holding current value
$6.79 Million
Previous $8.18 Million 8.54%
% of portfolio
0.36%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$111.15 - $128.97 $21,118 - $24,504
-190 Reduced 0.29%
65,847 $7.48 Million
Q2 2024

Jul 19, 2024
BUY
$123.8 - $132.96 $645,617 - $693,386
5,215 Added 8.57%
66,037 $8.18 Million
Q1 2024

Apr 15, 2024
BUY
$113.24 - $131.95 $706,051 - $822,708
6,235 Added 11.42%
60,822 $8.03 Million
Q4 2023

Jan 11, 2024
SELL
$100.18 - $109.02 $97,374 - $105,967
-972 Reduced 1.75%
54,587 $5.95 Million
Q3 2023

Oct 10, 2023
SELL
$102.95 - $114.33 $33,973 - $37,728
-330 Reduced 0.59%
55,559 $5.72 Million
Q2 2023

Jul 17, 2023
SELL
$108.61 - $118.38 $66,795 - $72,803
-615 Reduced 1.09%
55,889 $6.45 Million
Q1 2023

Apr 11, 2023
BUY
$102.94 - $114.86 $20,999 - $23,431
204 Added 0.36%
56,504 $6.01 Million
Q4 2022

Jan 19, 2023
BUY
$87.44 - $112.11 $67,328 - $86,324
770 Added 1.39%
56,300 $0
Q3 2022

Oct 13, 2022
SELL
$84.53 - $94.96 $18,004 - $20,226
-213 Reduced 0.38%
55,530 $4.78 Million
Q2 2022

Jul 07, 2022
BUY
$83.49 - $94.64 $11,939 - $13,533
143 Added 0.26%
55,743 $5.08 Million
Q1 2022

Apr 14, 2022
SELL
$73.51 - $82.4 $457,967 - $513,352
-6,230 Reduced 10.08%
55,600 $4.76 Million
Q4 2021

Jan 05, 2022
BUY
$72.28 - $90.54 $312,249 - $391,132
4,320 Added 7.51%
61,830 $4.74 Million
Q3 2021

Oct 05, 2021
BUY
$71.68 - $78.83 $17,920 - $19,707
250 Added 0.44%
57,510 $4.32 Million
Q2 2021

Jul 07, 2021
SELL
$70.31 - $77.77 $21,444 - $23,719
-305 Reduced 0.53%
57,260 $4.45 Million
Q1 2021

Apr 06, 2021
BUY
$68.86 - $81.11 $30,987 - $36,499
450 Added 0.79%
57,565 $4.43 Million
Q4 2020

Jan 11, 2021
SELL
$71.77 - $79.65 $32,296 - $35,842
-450 Reduced 0.78%
57,115 $4.67 Million
Q3 2020

Oct 08, 2020
SELL
$73.18 - $82.95 $483,646 - $548,216
-6,609 Reduced 10.3%
57,565 $4.78 Million
Q2 2020

Jul 08, 2020
SELL
$70.42 - $80.13 $1.49 Million - $1.7 Million
-21,172 Reduced 24.81%
64,174 $4.96 Million
Q1 2020

Apr 15, 2020
SELL
$63.36 - $87.82 $76,855 - $106,525
-1,213 Reduced 1.4%
85,346 $6.57 Million
Q4 2019

Jan 10, 2020
BUY
$77.58 - $87.54 $212,569 - $239,859
2,740 Added 3.27%
86,559 $7.87 Million
Q3 2019

Oct 07, 2019
SELL
$76.08 - $82.93 $8.47 Million - $9.24 Million
-111,378 Reduced 57.06%
83,819 $7.06 Million
Q2 2019

Jul 10, 2019
BUY
$69.84 - $81.59 $64,602 - $75,470
925 Added 0.48%
195,197 $16.4 Million
Q1 2019

Apr 05, 2019
BUY
$69.58 - $79.36 $1.13 Million - $1.29 Million
16,285 Added 9.15%
194,272 $16.2 Million
Q4 2018

Jan 07, 2019
SELL
$65.24 - $75.71 $58,715 - $68,139
-900 Reduced 0.5%
177,987 $13.6 Million
Q3 2018

Oct 12, 2018
BUY
$57.69 - $67.84 $15,864 - $18,656
275 Added 0.15%
178,887 $12.7 Million
Q2 2018

Jul 12, 2018
BUY
$50.83 - $59.72 $5.05 Million - $5.94 Million
99,409 Added 125.51%
178,612 $10.8 Million
Q1 2018

Apr 11, 2018
SELL
$50.96 - $59.23 $94,428 - $109,753
-1,853 Reduced 2.29%
79,203 $4.31 Million
Q4 2017

Jan 10, 2018
SELL
$51.62 - $61.64 $4.15 Million - $4.95 Million
-80,346 Reduced 49.78%
81,056 $4.56 Million
Q3 2017

Oct 13, 2017
BUY
$58.67 - $63.13 $9.47 Million - $10.2 Million
161,402
161,402 $10.3 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email